Nizatidine Market
Nizatidine Market Analysis By Type (Nizatidine Capsules, Nizatidine Tablets), By Distribution Channel (Nizatidine for Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & By Region - Global Insights to 2031
Analysis of Nizatidine market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Nizatidine
Newly published data by Fact.MR estimates the global market for nizatidine to flourish at an impressive 9% value CAGR across the 2021 to 2031 assessment period. Expected valuation for the market by the end of the said decade is likely to reach US$ 12.2 Bn, while as of 2021, the expected market value is US$ 5.1 Bn.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Key Points Covered in Nizatidine Industry Survey
- Market estimates and forecast 2016 to 2031
- Key drivers and restraints impacting market growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand share and Market Share Analysis
- Key Product Innovations and Regulatory Conditions
- COVID-19 Impact on Nizatidine Market and How to Navigate
- Recommendation on Key Winning Strategies
Consumption Analysis of Nizatidine 2016 to 2020 vs Outlook 2021 to 2031
According to Fact.MR- a market research and competitive intelligence provider- the market for nizatidine experienced a noteworthy upsurge from 2016 to 2020, expanding at a CAGR of 7%. Growth is riding on the back of rising prevalence of gastric disorders.
Attributed to its anti-inflammatory effects, nizatidine is being investigated in order to develop anti-viral drugs which could prove to be highly effective in countering the COVID-19 pandemic. Various pharmaceutical giants are ramping up efforts to fast track the development of nizatidine infused drugs.
In addition, numerous well-known companies have won approval to sell their products in new areas, boosting their growth chances. Over the forthcoming decade, the market is expected to grow at a rate of 9% in value CAGR terms.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Rising Healthcare Costs to Drive Nizatidine-based Treatment Market?
Globally, as healthcare infrastructure improves, overall spending on high-quality treatment is increasing. This is largely due to the combination of modern technologies and innovative therapeutic approaches. This is true even for the treatment of gastrointestinal problems.
Various pharmaceutical grade treatments, such as nizatidine medicines, have been developed as effective alternatives. These medications are readily available online or over-the-counter at low prices, making them accessible to people of all socioeconomic backgrounds.
How is Nizatidine Uptake Fueled by Increasing Awareness of Gastric Disorders?
According to the British Medical Association (BMA), non-communicable diseases (NCDs) account for 60% of the worldwide illness burden, with stomach disorders accounting for the majority of this total. As a result, regional-level measures are ongoing to address this issue.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is financing research studies in the United States to better understand the complex connections between genetic, environmental, immunological, and microbial variables that contribute to stomach disorders. Such endeavors are also assisting in the development of nizatidine-based medications.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Voluntary Product Recalls to Disrupt Nizatidine Market Expansion?
In 2020, the U.S Food and Drug Administration announced a voluntary recall of ranitidine and nizatidine tablets by two major manufacturers, Appco Pharma and Mylan N.V., in early 2020. While the former recalled all of its tablets, the latter pulled three batches of nizatidine capsules from the market.
The aforementioned recalls were prompted by a significant risk of contamination due to NDMA levels exceeding the FDA's permitted daily intake guidelines, which is a probable carcinogen. As a result, product releases are likely to be postponed, limiting growth opportunities.
Country-wise Analysis
Why will India Witness High Growth over the Upcoming Years?
According to the India Brand Equity Foundation , India is the world's largest provider of generic medications, and the home market is predicted to grow threefold by 2031, with medicine spending expected to increase by more than 9%. (IBEF). As a result, nizatidine sales are expected to grow in the next years.
Currently, nizatidine is produced in India by a small number of well-known pharmaceutical businesses. Glenmark Pharmaceuticals, Dr. Reddy's Laboratories, and Strides Pharma Science are the companies in question. More players are expected to emerge in the Indian environment as regulatory approvals are expedited. The Indian market is poised to surge at a CAGR of 8.5% by 2031, according to Fact.MR
What are the Prospects for Nizatidine Sales in the U.S?
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that 60 to 70 million people are affected by digestive diseases, with over 20 million hospitalizations. Diverticulosis, GI infections, and gastroesophageal reflux were among the most common.
As a result, the use of antihistamines to reduce excessive gastric juice production is on the rise, boosting nizatidine sales. Certain companies, such as Amneal Pharmaceuticals Inc., have been given permission to resume sales of their nizatidine oral solutions, indicating that future growth is possible. As per Fact.MR, the U.S market is poised to surge at a CAGR of 7.2% until 2031.
Why is China Expected to be an Attractive Market for Nizatidine?
It is apprehended that China accounts for a significant chunk of irritable bowel syndrome- affecting between 4 to 7% of the population. According to the National Center for Biotechnology Information (NCBI), China is one of the countries with the heaviest burden of gastric cancer (GC).
The number of incident cases of GC increased from 317.34 thousand in 1990 to 612.82 thousand in 2019, while the age-standardized incidence rate (ASIR) of GC decreased from 37.56 per 100,000 in 1990 to 30.64 per 100,000 in 2019, hence providing immense opportunities for enhanced nizatidine sales. Owing to these factors, sales of nizatidine drugs are likely to accelerate at an impressive 8% CAGR.
Category-wise Insights
Is Nizatidine Product Sales Increasing Through Retail and Online Channels?
While hospital pharmacies remain the principal source of nizatidine capsules and tablets, sales at retail and online pharmacies are fast expanding at a CAGR of about 14%, owing to the convenience of access and availability.
The fast growth of over-the-counter pharmacies and online medical stores is providing leading nizatidine manufacturers with a better platform to sell their medicines to potential customers.
Nizatidine Capsules to witness huge demand over the upcoming years?
Nizatidine capsule sales are expected to outperform other forms, such as tablets and powder, with a CAGR of over 10% from 2021 to 2031. These capsules are offered in two doses to treat duodenal ulcers: 150 mg and 300 mg, respectively.
Nizatidine capsules operate faster than tablets because they break down faster, and they are less likely to have a disagreeable taste or odor, which is especially useful for those who have trouble swallowing tablets.
Competitive Landscape
Prominent nizatidine manufacturers are reliant on regulatory sanctions from appropriate authorities to market their products, besides resorting to strategies such as mergers, acquisitions and collaborations.
- Glenmark Pharmaceuticals, a major Indian manufacturer, offers a range of Nizatidine Oral Capsules composed of a dosage of 300 milligrams, specifically manufactured for treating active duodenal ulcers.
- Likewise, Dr. Reddy’s Laboratories offers nizatidine for inhibiting gastrointestinal- GI H2 receptor antagonists which are synthetically manufactured and available in oral solid and liquid formats.
- MedChemExpress, another prominent player, manufactures nizatidine for uptake across stomach and intestine ulcers. It works by secreting the secretion of gastric acid the stomach produces, thereby preventing ulcer recurrence.
Report Scope
| Attribute | Details |
|---|---|
| Market size value in 2020 | USD 5.1 Billion |
| Market forecast value in 2031 | USD 12.2 Billion |
| Growth Rate | CAGR of 9% from 2021 to 2031 |
| Forecast Period | 2021 to 2031 |
| Historical Data Available for | 2016 to 2020 |
| Market Analysis | US$ Mn for Value & ‘000 Units for Volume |
| Key Regions Covered | North America; Europe; East Asia; South Asia; Oceania; Latin America; Middle East & Africa |
| Key Countries Covered |
U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K, Spain, Russia, India, ASEAN, China, Japan, South Korea, Australia, New Zealand, GCC, South Africa |
| Key Market Segments Covered | Type, Distribution Channel, Region |
| Key Companies Profiled | Flynn Pharma; MedChemExpress; Mylan N.V.; Glenmark Pharmaceuticals; Weightech (Hunan) Pharmaceutical; Hengdian Group; Dr. Reddy’s Laboratories; Eli Lily and Company; Strides Pharma Science Limited |
| Pricing | Available upon Request |
Key Segments Covered
-
By Type :
- Nizatidine Capsules
- Nizatidine Tablets
- Other Nizatidine Types
-
By Distribution Channel :
- Nizatidine for Hospital Pharmacies
- Nizatidine for Retail Pharmacies
- Nizatidine for Online Pharmacies
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Type
- 9.1. Capsules
- 9.2. Tablets
- 9.3. Others
- 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Application
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 13. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Key and Emerging Countries Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Flynn Pharma
- 21.2. MedChemExpress
- 21.3. Mylan N.V.
- 21.4. Glenmark Pharmaceuticals
- 21.5. Weightech (Hunan) Pharmaceutical
- 21.6. Hengdian Group
- 21.7. Dr. Reddy’s Laboratories
- 21.8. Eli Lilly and Company
- 21.9. Strides Pharma Science Limited
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 08: Latin America Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 11: Europe Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 14: South Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 17: East Asia Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 20: Oceania Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2016 to 2031, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2016 to 2020
Figure 02: Global Market Volume Forecast (in 000' Units), 2021 to 2031
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2016 to 2020
Figure 06: Global Market Value Forecast (US$ Mn), 2021 to 2031
Figure 07: Global Market Absolute $ Opportunity, 2021 to 2031
Figure 08: Global Market Share Analysis (%), By Type, 2021 to 2031
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2021 to 2031
Figure 10: Global Market Attractiveness Analysis by Type, 2021 to 2031
Figure 11: Global Market Share Analysis (%), By Application, 2021 to 2031
Figure 12: Global Market Y-o-Y Analysis (%), By Application, 2021 to 2031
Figure 13: Global Market Attractiveness Analysis by Application, 2021 to 2031
Figure 14: Global Market Share Analysis (%), By Region, 2021 to 2031
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2021 to 2031
Figure 16: Global Market Attractiveness Analysis by Region, 2021 to 2031
Figure 17: North America Market Value Share, By Type, 2021 (E)
Figure 18: North America Market Value Share, By Application, 2021 (E)
Figure 19: North America Market Value Share, By Country, 2021 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 21: North America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 22: North America Market Attractiveness Analysis by Type, 2021 to 2031
Figure 23: North America Market Attractiveness Analysis by Application, 2021 to 2031
Figure 24: North America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 25: Latin America Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Market Value Share, By Application, 2021 (E)
Figure 27: Latin America Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2016 to 2020
Figure 29: Latin America Market Value Forecast (US$ Mn), 2021 to 2031
Figure 30: Latin America Market Attractiveness Analysis by Type, 2021 to 2031
Figure 31: Latin America Market Attractiveness Analysis by Application, 2021 to 2031
Figure 32: Latin America Market Attractiveness Analysis by Country, 2021 to 2031
Figure 33: Europe Market Value Share, By Type, 2021 (E)
Figure 34: Europe Market Value Share, By Application, 2021 (E)
Figure 35: Europe Market Value Share, By Country, 2021 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2016 to 2020
Figure 37: Europe Market Value Forecast (US$ Mn), 2021 to 2031
Figure 38: Europe Market Attractiveness Analysis by Type, 2021 to 2031
Figure 39: Europe Market Attractiveness Analysis by Application, 2021 to 2031
Figure 40: Europe Market Attractiveness Analysis by Country, 2021 to 2031
Figure 41: South Asia Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Market Value Share, By Application, 2021 (E)
Figure 43: South Asia Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 45: South Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 46: South Asia Market Attractiveness Analysis by Type, 2021 to 2031
Figure 47: South Asia Market Attractiveness Analysis by Application, 2021 to 2031
Figure 48: South Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 49: East Asia Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Market Value Share, By Application, 2021 (E)
Figure 51: East Asia Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2016 to 2020
Figure 53: East Asia Market Value Forecast (US$ Mn), 2021 to 2031
Figure 54: East Asia Market Attractiveness Analysis by Type, 2021 to 2031
Figure 55: East Asia Market Attractiveness Analysis by Application, 2021 to 2031
Figure 56: East Asia Market Attractiveness Analysis by Country, 2021 to 2031
Figure 57: Oceania Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Market Value Share, By Application, 2021 (E)
Figure 59: Oceania Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2016 to 2020
Figure 61: Oceania Market Value Forecast (US$ Mn), 2021 to 2031
Figure 62: Oceania Market Attractiveness Analysis by Type, 2021 to 2031
Figure 63: Oceania Market Attractiveness Analysis by Application, 2021 to 2031
Figure 64: Oceania Market Attractiveness Analysis by Country, 2021 to 2031
Figure 65: Middle East and Africa Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa Market Value Share, By Application, 2021 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2016 to 2020
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2021 to 2031
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2021 to 2031
Figure 71: Middle East and Africa Market Attractiveness Analysis by Application, 2021 to 2031
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2021 to 2031
Figure 73: U. S. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Market Value Share, By Application, 2021 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Market Value Share, By Type, 2021 (E)
Figure 78: Canada Market Value Share, By Application, 2021 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Market Value Share, By Application, 2021 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Market Value Share, By Application, 2021 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Market Value Share, By Application, 2021 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Market Value Share, By Type, 2021 (E)
Figure 90: Germany Market Value Share, By Application, 2021 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Market Value Share, By Type, 2021 (E)
Figure 93: France Market Value Share, By Application, 2021 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Market Value Share, By Type, 2021 (E)
Figure 96: Italy Market Value Share, By Application, 2021 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Market Value Share, By Type, 2021 (E)
Figure 99: Spain Market Value Share, By Application, 2021 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Market Value Share, By Type, 2021 (E)
Figure 102: Russia Market Value Share, By Application, 2021 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Market Value Share, By Type, 2021 (E)
Figure 105: China Market Value Share, By Application, 2021 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Market Value Share, By Type, 2021 (E)
Figure 108: Japan Market Value Share, By Application, 2021 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Market Value Share, By Application, 2021 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Market Value Share, By Type, 2021 (E)
Figure 114: India Market Value Share, By Application, 2021 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Market Value Share, By Application, 2021 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Market Value Share, By Type, 2021 (E)
Figure 120: Australia Market Value Share, By Application, 2021 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Market Value Share, By Application, 2021 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Market Value Share, By Application, 2021 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Market Value Share, By Application, 2021 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Market Value Share, By Application, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the nizatidine industry worth?
According to Fact.MR, nizatidine sales are expected to reach US$ 5.1 Bn as of 2021
What was the last 5 years market CAGR for nizatidine?
From 2016 to 2020, nizatidine sales expanded at a CAGR of 7% according to Fact.MR
What is the anticipated outlook for the nizatidine market until 2031?
From 2021 to 2031, nizatidine sales are expected to register a CAGR of 9% in value terms
What is the expected market value for nizatidine as of 2031?
As of 2031, nizatidine sales are expected to be valued at US$ 12.2 Bn according to Fact.MR
What is driving demand for nizatidine medicines?
The ever increasing burden of gastric disorders and other chronic ailments will likely spur sales of nizatidine drugs
What are the expansion prospects in the U.S?
Nizatidine sales in the U.S are expected to register a CAGR of 7.2% from 2021 to 2031
How lucrative are growth prospects across India?
The Indian market for nizatidine is poised to expand 3x from 2021 to 2031, as per Fact.MR
What growth prospects abound across the market in China?
According to Fact.MR, China is expected to register a CAGR of 8% from 2021 to 2031
Which type of nizatidine drugs are expected to remain in the limelight?
Nizatidine capsules are expected to experience a staggering 10% CAGR until 2031
Which are some prominent manufacturers of nizatidine?
Flynn Pharma, MedChemExpress and Glenmark Pharmaceuticals are some prominent nizatidine manufacturers profiled by Fact.MR.
Nizatidine Market